VanEck Pharmaceutical ETF PPH
121.71 USD +0.13 (+0.11%)
At closeNov 11, 2026, 5:28 PM EST
121.92 +0.21 +0.17%
After hours · Nov 11, 5:28 PM ET
120.07 Day range 121.83
97.52 52-week range 123.53
- YTD
- +17.97%
- 1 year
- +23.94%
- Market cap
- 1.10B
- EPS (ttm)
- 4.29
- P/E ratio
- 28.40
- YTD return
- +17.97%
- 1-year return
- +23.94%
- Volume
- 236.02K
- Avg volume
- 323.87K
- Open
- 120.50
- Previous close
- 121.58
- Day's range
- 120.07 – 121.83
- 52-week range
- 97.52 – 123.53
5D -0.76 (-0.62%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 113.25
- 200-day average
- 108.41
About VanEck Pharmaceutical ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
News
ETFs in Spotlight as FDA Vision Loss Warning Meets Lilly's Sleep Apnea Win 
Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF 
PPH: Key Pharmaceutical Innovations Support Bullish Outlook (Upgrade) 
Which Pharmaceutical ETF Is the Better Buy: iShares’ Domestic IHE or VanEck’s Global PPH? 
Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH? 
Execution of Pharma Tariffs Brings These ETFs Into Focus 
Should You Invest in the VanEck Pharmaceutical ETF (PPH)? 
Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP 
VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits? 
Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs.
Your note
Sign in to keep a note on PPH — it syncs with the Stock Master app.